Cannabis Stocks

[Nopoo]

NEWS - BBT.C - Benchmark Signs Definitive Investment Cooperation Agreement with Fortune 500 China-Based Zhejiang Yatai Pharmaceutical

 

 

https://benchmarkbotanics.com/investors/new...nt20190529.html

 

 

 

http://en.yatai.com/

 

 

https://benchmarkbotanics.com

 

 

 

[blacksheep]

Pot stocks given the chop

 

Aussie brokers burned by Pershing's potty move

BNY Mellon's Pershing will no longer accept incoming positions, or trading of non-permitted Cannabis Related Business securities," Pershing told its clients, via an email seen by Street Talk.

 

While the ban is global, it has seen seven ASX-listed pot stocks given the chop.

 

The unlucky seven were Auscann Group, Cann Group, CannPal Animal Therapeutics, Creso Pharma, MGC Pharmaceuticals, MMJ Group and Zelda Therapeutics. Another 20-odd were "to be reviewed".

 

read more - https://www.afr.com/street-talk/aussie-brok...20191119-p53bu5

[blacksheep]

A couple of charts showing the rise, and fall, of some of the pot stocks mentioned below

[Nopoo]

NEWS - BBT.C - Benchmark Botanics Receives 2nd Cannabis Cultivation Licence

https://www.newsfilecorp.com/release/50365

 

 

http://benchmarkbotanics.com

 

[nipper]

Epsilon Healthcare Limited (ASX:EPN), formerly THC Global Group Limited (THC) , confirms that following shareholder approval on 18 February 2021, the Company has now been renamed Epsilon Healthcare Limited and will commence trading under the ASX Code EPN from today, Thursday, 25 February 2021.

 

Group Chief Executive Officer, Jarrod White commented:

The now complete rebranding of the Company to Epsilon Healthcare Limited better reflects the Company’s current approach as a healthcare and pharmaceuticals business with significant investment in the medicinal cannabis space in Australia and Canada. We look forward to continuing to develop our high value pharmaceuticals manufacturing business in Southport, our healthcare clinics, the Medimar platform, and our hydroponic cultivation service offerings globally under this new brand and strategy.

Epsilon Healthcare Limited (ASX: EPN) is a diversified global healthcare and pharmaceuticals company. EPN owns a number of medicinal cannabis assets including the largest cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic group, and the Medimar Platform – an end-to-end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.